These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 3227035)

  • 1. Disruption of latent inhibition by acute administration of low doses of amphetamine.
    Weiner I; Lubow RE; Feldon J
    Pharmacol Biochem Behav; 1988 Aug; 30(4):871-8. PubMed ID: 3227035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitation of the expression but not the acquisition of latent inhibition by haloperidol in rats.
    Weiner I; Feldon J; Katz Y
    Pharmacol Biochem Behav; 1987 Feb; 26(2):241-6. PubMed ID: 3575349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abolition of the acquisition but not the expression of latent inhibition by chlordiazepoxide in rats.
    Feldon J; Weiner I
    Pharmacol Biochem Behav; 1989 Jan; 32(1):123-7. PubMed ID: 2734324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of intra-accumbens and systemic amphetamine on latent inhibition using an on-baseline, within-subject conditioned suppression paradigm.
    Killcross AS; Robbins TW
    Psychopharmacology (Berl); 1993; 110(4):479-89. PubMed ID: 7870920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latent inhibition is not affected by acute or chronic administration of 6 mg/kg dl-amphetamine.
    Weiner I; Izraeli-Telerant A; Feldon J
    Psychopharmacology (Berl); 1987; 91(3):345-51. PubMed ID: 3104957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phencyclidine does not disrupt latent inhibition in rats: implications for animal models of schizophrenia.
    Weiner I; Feldon J
    Pharmacol Biochem Behav; 1992 Aug; 42(4):625-31. PubMed ID: 1513845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphetamine-induced disruption and haloperidol-induced potentiation of latent inhibition depend on the nature of the stimulus.
    Ruob C; Elsner J; Weiner I; Feldon J
    Behav Brain Res; 1997 Oct; 88(1):35-41. PubMed ID: 9401706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single administration of d-amphetamine prior to stimulus pre-exposure and conditioning attenuates latent inhibition.
    McAllister KH
    Psychopharmacology (Berl); 1997 Mar; 130(2):79-84. PubMed ID: 9106903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of phencyclidine on latent inhibition in taste aversion conditioning: differential effects of preexposure and conditioning.
    Pålsson E; Klamer D; Wass C; Archer T; Engel JA; Svensson L
    Behav Brain Res; 2005 Feb; 157(1):139-46. PubMed ID: 15617780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphetamine-induced disruptions of latent inhibition are reinforcer mediated: implications for animal models of schizophrenic attentional dysfunction.
    Killcross AS; Dickinson A; Robbins TW
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):185-95. PubMed ID: 7862894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine manipulations limited to preexposure are sufficient to modulate latent inhibition.
    Bethus I; Muscat R; Goodall G
    Behav Neurosci; 2006 Jun; 120(3):554-62. PubMed ID: 16768607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of striatal or accumbens lesions on the amphetamine-induced abolition of latent inhibition.
    Konstandi M; Kafetzopoulos E
    Pharmacol Biochem Behav; 1993 Apr; 44(4):751-4. PubMed ID: 8469686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latent inhibition is disrupted by nucleus accumbens shell lesion but is abnormally persistent following entire nucleus accumbens lesion: The neural site controlling the expression and disruption of the stimulus preexposure effect.
    Gal G; Schiller D; Weiner I
    Behav Brain Res; 2005 Jul; 162(2):246-55. PubMed ID: 15970218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facilitation of latent inhibition by haloperidol in rats.
    Weiner I; Feldon J
    Psychopharmacology (Berl); 1987; 91(2):248-53. PubMed ID: 3107041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of tail-pressure stress and d-amphetamine in disruption of the rat's ability to ignore an irrevelant stimulus.
    Hellman PA; Crider A; Solomon PR
    Behav Neurosci; 1983 Dec; 97(6):1017-21. PubMed ID: 6651958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sigma ligand BMY-14802 as a potential antipsychotic: evidence from the latent inhibition model in rats.
    Weiner I; Traub A; Rawlins JN; Smith AD; Feldon J
    Behav Pharmacol; 1995 Jan; 6(1):46-54. PubMed ID: 11224311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A neurotoxic lesion of serotonergic neurones using 5,7-dihydroxytryptamine does not disrupt latent inhibition in paradigms sensitive to low doses of amphetamine.
    De Oliveira Mora P; Fouquet N; Oberling P; Gobaille S; Graeff FG; Sandner G
    Behav Brain Res; 1999 Apr; 100(1-2):167-75. PubMed ID: 10212064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine and haloperidol reinstate latent inhibition following its disruption during amphetamine withdrawal.
    Russig H; Murphy CA; Feldon J
    Neuropsychopharmacology; 2002 Jun; 26(6):765-77. PubMed ID: 12007747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of (+)-amphetamine and apomorphine on responding for a conditioned reinforcer.
    Mazurski EJ; Beninger RJ
    Psychopharmacology (Berl); 1986; 90(2):239-43. PubMed ID: 3097705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The latent inhibition model of schizophrenic attention disorder. Haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli.
    Feldon J; Weiner I
    Biol Psychiatry; 1991 Apr; 29(7):635-46. PubMed ID: 2054435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.